Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence.
Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, Sung PJ, Chen JC, Weng CF. · 2020
Read Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. by Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, Sung PJ, Chen JC, Weng CF. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7056458.txt.
Description
Lin and co-authors assess natural compounds as helpers in cancer therapy in the British Journal of Pharmacology. Standard chemotherapy suffers from toxicity throughout the body. Combining several drugs with different targets already improves efficacy and softens side effects. Plant-based products offer a less toxic source of partners, and interest in them as adjuvants keeps growing.
Laboratory evidence suggests herbal extracts such as Solanum nigrum and Claviceps purpurea can help. Pure compounds including curcumin, resveratrol, and matairesinol can weaken cancer's resistance to drugs and protect healthy tissue when paired with antitumour medicines. Traditional Chinese medicine used alongside chemotherapy has improved quality of life and eased bone marrow suppression in lung and gastric cancer studies. The authors add a caution: plant products carry their own adverse effects and can interact with drugs. More work is needed before such supplements earn a routine place.
Catalog record
| CREATOR | Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, Sung PJ, Chen JC, Weng CF. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |